EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation

Emmanuel Faderin, Terungwa H Iorkula, Omowunmi Rebecca Aworinde, Raymond Femi Awoyemi, Christopher Taiwo Awoyemi, Edward Acheampong, Peter Agyemang, Gregory E Onaiwu, Ikhazuagbe Hilary Ifijen

Medical Oncology · 2025

DOI: 10.1007/s12032-024-02598-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, 2025. Verfasst von Emmanuel Faderin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Southern Illinois University, Edwardsville, 1 Hairpin Drive, Edwardsville, IL, 62026-001, USA. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Neoplasms, Antineoplastic Agents, Metal Nanoparticles. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 237 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum nanoparticles (PtNPs) offer significant promise in cancer therapy by enhancing the therapeutic effects of platinum-based chemotherapies like cisplatin. These nanoparticles improve tumor targeting, reduce off-target effects, and help overcome drug resistance. PtNPs exert their anti-cancer effects primarily through the generation of reactive oxygen species (ROS), which induce oxidative stress and apoptosis in cancer cells. Additionally, PtNPs interact with cellular signaling pathways such as PI3K/AKT and MAPK, sensitizing cancer cells to chemotherapy. Advances in PtNP synthesis focus on optimizing size, shape, and surface modifications to enhance biocompatibility and targeting. Functionalization with biomolecules allows selective tumor delivery, while smart release systems enable controlled drug release. In vivo studies have shown that PtNPs significantly inhibit tumor growth and metastasis. Ongoing clinical trials are evaluating their safety and efficacy. This review explores PtNPs' mechanisms of action, nanotechnology advancements, and challenges in biocompatibility, with a focus on their potential integration into cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesNeoplasmsAntineoplastic AgentsMetal NanoparticlesPlatinumHumansAnimals

Stichwörter der Autor:innen

Cancer therapyChemotherapeutic enhancementCisplatinNanomedicinePlatinum nanoparticlesReactive oxygen species

Substanzen

Reactive Oxygen SpeciesAntineoplastic AgentsPlatinum

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Southern Illinois University, Edwardsville, 1 Hairpin Drive, Edwardsville, IL, 62026-001, USA.
  • Department of Chemistry and Biochemistry, Brigham Young University Provo, Provo, UT, USA.
  • Department of Chemistry, Michigan Technological University, 1400 Townsend Dr, Houghton, MI, 49931, USA.
  • Department of Chemistry, Mississippi State University, Starkville, MS, 39762, USA.
  • Laboratory Department, Covenant University Medical Centre, Canaanland, KM 10, Idiroko Road, Ota, Ogun State, Nigeria.
  • Department of Physical Science (Chemistry Option), Benson Idahosa University, PMB 1100, Benin City, Edo State, Nigeria.

Zitieren

APA

Faderin, E., Iorkula, T. H., Aworinde, O. R., Awoyemi, R. F., Awoyemi, C. T., Acheampong, E., Agyemang, P., Onaiwu, G. E., & Ifijen, I. H. (2025). Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation. Medical Oncology. https://doi.org/10.1007/s12032-024-02598-w

Vancouver

Faderin E, Iorkula TH, Aworinde OR, Awoyemi RF, Awoyemi CT, Acheampong E, et al. Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation. Medical Oncology. 2025. doi:10.1007/s12032-024-02598-w

BibTeX
@article{Faderin2025,
  author = {Faderin, Emmanuel and Iorkula, Terungwa H and Aworinde, Omowunmi Rebecca and Awoyemi, Raymond Femi and Awoyemi, Christopher Taiwo and Acheampong, Edward and Agyemang, Peter and Onaiwu, Gregory E and Ifijen, Ikhazuagbe Hilary},
  title = {Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-024-02598-w}
}
Kostenlos starten →